Cyclin dependent kinase 4/6 inhibitors in early breast cancer: what is the role of Ki-67?

Lancet Oncol. 2022 Mar;23(3):325-328. doi: 10.1016/S1470-2045(21)00756-7.
No abstract available

MeSH terms

  • Biomarkers, Tumor / metabolism
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Clinical Trials as Topic
  • Cyclin-Dependent Kinase 4 / antagonists & inhibitors*
  • Cyclin-Dependent Kinase 6 / antagonists & inhibitors*
  • Female
  • Humans
  • Ki-67 Antigen / metabolism*
  • Protein Kinase Inhibitors / therapeutic use
  • Risk Assessment

Substances

  • Biomarkers, Tumor
  • Ki-67 Antigen
  • Protein Kinase Inhibitors
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinase 6